{"id":"93fd808a-98f2-54fa-a8ec-4237a838ef9d","stable_key":"8b3cf083-ea9c-54f5-b42b-bf1fef5b2978:metformin-ampk-srebp1","predicate":"suppresses","statement":"Activation of AMPK by metformin suppressed expression of SREBP-1, and hepatic lipogenic mRNA and protein were reduced in metformin-treated rats.","claim_class":"mechanistic","status":"source_derived_draft","evidence_grade":"ungraded","direction":"negative","is_public":true,"mechanism_event_id":"710cdd0e-3d00-5d1d-b689-9d4151a8220a","mechanism_event_label":"The switch reaches the transcription factor that drives fat synthesis.","subject":{"id":"8128eec0-61cc-51ef-8d4e-5ec9678e8dfa","slug":"ampk-complexes","display_name":"AMP-activated protein kinase complexes","entity_type_key":"protein_family"},"object":{"id":"278d2aa8-ed70-58ab-8650-3d9b32f725b5","slug":"srebf1","display_name":"Sterol regulatory element-binding protein 1 / SREBP-1","entity_type_key":"protein"},"evidence_count":1,"mechanism_event":{"id":"710cdd0e-3d00-5d1d-b689-9d4151a8220a","stable_key":"8b3cf083-ea9c-54f5-b42b-bf1fef5b2978:metformin-ampk-srebp1-event","event_type":"biochemical_relationship","label":"The switch reaches the transcription factor that drives fat synthesis.","description":"Activation of AMPK by metformin suppressed expression of SREBP-1, and hepatic lipogenic mRNA and protein were reduced in metformin-treated rats.","status":"provisional","compartment":null,"participants":[{"entity":{"id":"519971b1-5aef-5ad7-8022-840144855cd0","slug":"metformin","display_name":"Metformin","entity_type_key":"drug"},"role":"upstream_actor","stoichiometry":null,"state_label":"","sequence_order":0,"notes":""},{"entity":{"id":"09fec4e6-884b-5426-9721-2d4bbf7f1b4b","slug":"lipogenic-gene-expression","display_name":"Hepatic lipogenic gene expression","entity_type_key":"cellular_process"},"role":"downstream_process","stoichiometry":null,"state_label":"","sequence_order":1,"notes":""},{"entity":{"id":"8128eec0-61cc-51ef-8d4e-5ec9678e8dfa","slug":"ampk-complexes","display_name":"AMP-activated protein kinase complexes","entity_type_key":"protein_family"},"role":"subject","stoichiometry":null,"state_label":"","sequence_order":2,"notes":""},{"entity":{"id":"278d2aa8-ed70-58ab-8650-3d9b32f725b5","slug":"srebf1","display_name":"Sterol regulatory element-binding protein 1 / SREBP-1","entity_type_key":"protein"},"role":"target","stoichiometry":null,"state_label":"","sequence_order":3,"notes":""}]},"contexts":[{"dimension":"evidence_span","value_text":"{\"source_cache\": \"artifacts/metformin-research/11602624.abstract.txt\", \"locator\": \"Indexed abstract; zero-based, end-exclusive Unicode character offsets\", \"file_sha256\": \"86e283289def8a6e3e3098d49f321dbcca9a6cd4677ba84f26daf17467179237\", \"start_char\": 0, \"end_char\": 1390, \"text_sha256\": \"86e283289def8a6e3e3098d49f321dbcca9a6cd4677ba84f26daf17467179237\"}","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"experimental_model","value_text":"Rat hepatocytes, isolated rat skeletal muscle and metformin-treated rats with an AMPK inhibitor","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"exposure","value_text":"Metformin in hepatocytes and in vivo; compound C AMPK inhibition","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"limitations","value_text":"The inhibitor experiment supports a requirement for AMPK in these hepatocytes; later work in AMPK-deficient mice reached a different conclusion, recorded separately.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"nutrient_topic","value_text":"Metformin research collection; topical membership is not evidence of a direct clinical effect, and pharmacological exposure is not dietary intake.","comparator":null,"unit":null,"notes":"","entity":{"slug":"metformin","display_name":"Metformin","entity_type_key":"drug"}},{"dimension":"organism","value_text":"Rat","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"plain_language","value_text":"The switch reaches the transcription factor that drives fat synthesis.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"primary_references","value_text":"[metformin-p11602624] Role of AMP-activated protein kinase in mechanism of metformin action. (2001). https://pubmed.ncbi.nlm.nih.gov/11602624/ DOI: 10.1172/jci13505","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"tissue_or_cell_type","value_text":"Liver and skeletal muscle","comparator":null,"unit":null,"notes":"","entity":null}],"evidence":[{"id":"a9f4f6f4-94ef-53bd-a78b-b2fdd3815bd6","evidence_kind":"source_excerpt","locator":"Lines 541-552","start_line":541,"end_line":552,"excerpt":"### metformin-ampk-srebp1\nActivation of AMPK by metformin suppressed expression of SREBP-1, and hepatic lipogenic mRNA and protein were reduced in metformin-treated rats.\nCondition category: normal\nnutrient_topic: Metformin research collection; topical membership is not evidence of a direct clinical effect, and pharmacological exposure is not dietary intake.\nplain_language: The switch reaches the transcription factor that drives fat synthesis.\norganism: Rat\ntissue_or_cell_type: Liver and skeletal muscle\nexperimental_model: Rat hepatocytes, isolated rat skeletal muscle and metformin-treated rats with an AMPK inhibitor\nlimitations: The inhibitor experiment supports a requirement for AMPK in these hepatocytes; later work in AMPK-deficient mice reached a different conclusion, recorded separately.\nexposure: Metformin in hepatocytes and in vivo; compound C AMPK inhibition\nevidence_span: {\"source_cache\": \"artifacts/metformin-research/11602624.abstract.txt\", \"locator\": \"Indexed abstract; zero-based, end-exclusive Unicode character offsets\", \"file_sha256\": \"86e283289def8a6e3e3098d49f321dbcca9a6cd4677ba84f26daf17467179237\", \"start_char\": 0, \"end_char\": 1390, \"text_sha256\": \"86e283289def8a6e3e3098d49f321dbcca9a6cd4677ba84f26daf17467179237\"}\n[metformin-p11602624] Role of AMP-activated protein kinase in mechanism of metformin action. (2001). https://pubmed.ncbi.nlm.nih.gov/11602624/ DOI: 10.1172/jci13505","model_system":"Rat hepatocytes, isolated rat skeletal muscle and metformin-treated rats with an AMPK inhibitor","directness":"author_interpretation","verification_status":"source_derived_draft","notes":"Exact curation-document quotation, not publisher quotation. Study references: [metformin-p11602624] Role of AMP-activated protein kinase in mechanism of metformin action. (2001). https://pubmed.ncbi.nlm.nih.gov/11602624/ DOI: 10.1172/jci13505","relationship":"supports","weight":1.0,"link_notes":"","source":{"id":"d0474bd9-7cfd-5695-a152-12f3633a6813","stable_key":"import-8b3cf083-ea9c-54f5-b42b-bf1fef5b2978","title":"Metformin: transport, molecular targets, gut mechanisms and nutrient interactions (2026-09-19)","document_type":"imported_text","citation_label":"AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text.","file_path":"","sha256":"0b51d0759aeeb88ac5b3a6277245a196b2bb024d7c32ec89379ed428fb06bfb5","revision_id":"0405c75e-f06e-5af7-a642-1777802f6004","review_status":"unverified_draft","notes":""}}],"relations":[],"conflicts":[],"corrections":[],"research":null}